Omada Health, Inc. received an amended Schedule 13G/A reflecting updated ownership by several investors in its common stock. U.S. Venture Partners X, L.P., USVP X Affiliates, L.P., and Presidio Management Group X, L.L.C. each report beneficial ownership of 0 shares, representing 0% of the class.
By contrast, Casey M. Tansey, through a trust for his benefit, reports beneficial ownership of 138,082 shares of common stock, with sole voting and dispositive power over those shares. This represents 0.2% of Omada Health’s common stock, based on 57,908,047 shares outstanding as of November 5, 2025. All Reporting Persons state that they own 5% or less of the class.
Positive
None.
Negative
None.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Omada Health, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
68170A108
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
68170A108
1
Names of Reporting Persons
U.S. Venture Partners X, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
68170A108
1
Names of Reporting Persons
USVP X Affiliates, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
68170A108
1
Names of Reporting Persons
Presidio Management Group X, L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
68170A108
1
Names of Reporting Persons
Casey M Tansey
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
138,082.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
138,082.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
138,082.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.2 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: These shares are held by a trust for the benefit of the Reporting Person. The amount beneficially owned by each Reporting Person is determined based on 57,908,047 shares of Common Stock outstanding as of November 5, 2025 as reported by the Issuer in its Form 10-Q.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Omada Health, Inc.
(b)
Address of issuer's principal executive offices:
611 Gateway Blvd, Suite 120, South San Francisco, CA 94080
Item 2.
(a)
Name of person filing:
This Schedule 13G is being filed on behalf of (i) U.S. Venture Partners X, L.P., a Delaware limited partnership, (ii) USVP X Affiliates, L.P., a Delaware limited partnership, (iii) Presidio Management Group X, L.L.C., a Delaware limited liability company and (iv) Casey M. Tansey, a citizen of the United States (the foregoing entities and individuals are collectively referred to as the Reporting Persons). The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached as Exhibit 1 to the original Schedule 13G. Other than those securities reported herein as being held directly by such Reporting Person, each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein.
(b)
Address or principal business office or, if none, residence:
The principal business office of the Reporting Persons is 1460 El Camino Real, Suite 100, Menlo Park, California 94025.
(c)
Citizenship:
See Item 2(a)
(d)
Title of class of securities:
Common Stock, par value $0.001 per share
(e)
CUSIP No.:
68170A108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See Row 9 of the cover page for each Reporting Person and the corresponding comments.
(b)
Percent of class:
See Row 11 of the cover page for each Reporting Person and the corresponding comments.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Row 5 of the cover page for each Reporting Person and the corresponding comments.
(ii) Shared power to vote or to direct the vote:
See Row 6 of the cover page for each Reporting Person and the corresponding comments.
(iii) Sole power to dispose or to direct the disposition of:
See Row 7 of the cover page for each Reporting Person and the corresponding comments.
(iv) Shared power to dispose or to direct the disposition of:
See Row 8 of the cover page for each Reporting Person and the corresponding comments.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
U.S. Venture Partners X, L.P.
Signature:
/s/ Dale Holladay
Name/Title:
Dale Holladay, Authorized Signatory
Date:
02/17/2026
USVP X Affiliates, L.P.
Signature:
/s/ Dale Holladay
Name/Title:
Dale Holladay, Authorized Signatory
Date:
02/17/2026
Presidio Management Group X, L.L.C.
Signature:
/s/ Dale Holladay
Name/Title:
Dale Holladay, Authorized Signatory
Date:
02/17/2026
Casey M Tansey
Signature:
/s/ Dale Holladay, Attorney-in-Fact for Casey M. Tansey
What does Omada Health (OMDA) Schedule 13G/A Amendment No. 1 show about USVP ownership?
The amended Schedule 13G/A shows U.S. Venture Partners X, L.P., USVP X Affiliates, L.P., and Presidio Management Group X, L.L.C. each report beneficial ownership of 0 Omada Health common shares, corresponding to 0% of the outstanding common stock class.
How many Omada Health (OMDA) shares does Casey M. Tansey beneficially own in this Schedule 13G/A?
Casey M. Tansey is reported as beneficially owning 138,082 Omada Health common shares. He has sole voting and dispositive power over these shares, which are held by a trust for his benefit, and this stake represents 0.2% of the company’s common stock.
On what share count is the 0.2% Omada Health (OMDA) ownership figure for Casey M. Tansey based?
The 0.2% ownership figure for Casey M. Tansey is calculated using 57,908,047 Omada Health common shares outstanding. This outstanding share count is stated as of November 5, 2025, in the company’s Form 10-Q, which the Schedule 13G/A references for its percentage computation.
Which class of Omada Health (OMDA) securities is covered by this Schedule 13G/A/A?
The Schedule 13G/A covers Omada Health’s common stock, with a par value of $0.001 per share. The filing specifically identifies this security class and references its CUSIP number 68170A108, clarifying that the reported ownership relates only to this common stock.
What does Item 5 in the Omada Health (OMDA) Schedule 13G/A indicate about ownership thresholds?
Item 5 states that the Reporting Persons each own 5 percent or less of Omada Health’s common stock class. This confirms that none of the listed investors, including Casey M. Tansey and the USVP entities, meets the 5% beneficial ownership threshold as of the reported date.
Who are the Reporting Persons in Omada Health (OMDA) Schedule 13G/A Amendment No. 1?
The Reporting Persons are U.S. Venture Partners X, L.P., USVP X Affiliates, L.P., Presidio Management Group X, L.L.C., and Casey M. Tansey. They file jointly but expressly disclaim status as a “group,” other than for the joint filing agreement referenced in the Schedule 13G/A.